Citation: G. Carcelain et al., Reconstitution of CD4(+) T lymphocytes in HIV-infected individuals following antiretroviral therapy, CURR OP IM, 13(4), 2001, pp. 483-488
Authors:
Ngo-Giang-Huong, N
Candotti, D
Goubar, A
Autran, B
Maynart, M
Sicard, D
Clauvel, JP
Agut, H
Costagliola, D
Rouzioux, C
Citation: N. Ngo-giang-huong et al., HIV type 1-specific IgG2 antibodies: Markers of helper T cell type 1 response and prognostic marker of long-term nonprogression, AIDS RES H, 17(15), 2001, pp. 1435-1446
Authors:
Ruiz, L
Carcelain, G
Martinez-Picado, J
Frost, S
Marfil, S
Paredes, R
Romeu, J
Ferrer, E
Morales-Lopetegi, K
Autran, B
Clotet, B
Citation: L. Ruiz et al., HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection, AIDS, 15(9), 2001, pp. F19-F27
Authors:
Girard, PM
Schneider, V
Dehee, A
Mariot, P
Jacomet, C
Delphin, N
Damond, F
Carcelain, G
Autran, B
Saimot, AG
Nicolas, JC
Rozenbaum, W
Citation: Pm. Girard et al., Treatment interruption after one year of triple nucleoside analogue therapy for primary HIV infection, AIDS, 15(2), 2001, pp. 275-277
Authors:
Delaugerre, C
Valantin, MA
Mouroux, M
Bonmarchand, M
Carcelain, G
Duvivier, C
Tubiana, R
Simon, A
Bricaire, F
Agut, H
Autran, B
Katlama, C
Calvez, V
Citation: C. Delaugerre et al., Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure, AIDS, 15(16), 2001, pp. 2189-2191
Authors:
Jouan, M
Saves, M
Tubiana, R
Carcelain, G
Cassoux, N
Aubron-Olivier, C
Fillet, AM
Nciri, M
Senechal, B
Chene, G
Tural, C
Lasry, S
Autran, B
Katlama, C
Citation: M. Jouan et al., Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy, AIDS, 15(1), 2001, pp. 23-31
Authors:
Carcelain, G
Tubiana, R
Samri, A
Calvez, V
Delaugerre, C
Agut, H
Katlama, C
Autran, B
Citation: G. Carcelain et al., Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection, J VIROLOGY, 75(1), 2001, pp. 234-241
Authors:
Hosmalin, A
Samri, A
Dumaurier, MJ
Dudoit, Y
Oksenhendler, E
Karmochkine, M
Autran, B
Wain-Hobson, S
Cheynier, R
Citation: A. Hosmalin et al., HIV-specific effector cytotoxic T lymphocytes and HIV-producing cells colocalize in white pulps and germinal centers from infected patients, BLOOD, 97(9), 2001, pp. 2695-2701
Authors:
McIlroy, D
Troadec, C
Grassi, F
Samri, A
Barrou, B
Autran, B
Debre, P
Feuillard, J
Hosmalin, A
Citation: D. Mcilroy et al., Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors, BLOOD, 97(11), 2001, pp. 3470-3477
Authors:
Hubert, P
Bergeron, F
Ferreira, V
Seligmann, M
Oksenhendler, E
Debre, P
Autran, B
Citation: P. Hubert et al., Defective p56(Lck) activity in T cells from an adult patient with idiopathic CD4(+) lymphocytopenia, INT IMMUNOL, 12(4), 2000, pp. 449-457
Authors:
Brando, B
Barnett, D
Janossy, G
Mandy, F
Autran, B
Rothe, G
Scarpati, B
D'Avanzo, G
D'Hautcourt, JL
Lenkei, R
Schmitz, G
Kunkl, A
Chianese, R
Papa, S
Gratama, JW
Citation: B. Brando et al., Cytofluorometric methods for assessing absolute numbers of cell subsets inblood, CYTOMETRY, 42(6), 2000, pp. 327-346
Authors:
Gabarre, J
Azar, N
Autran, B
Katlama, C
Leblond, V
Citation: J. Gabarre et al., High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma, LANCET, 355(9209), 2000, pp. 1071-1072
Authors:
Hassaine, G
Agostini, I
Candotti, D
Bessou, G
Caballero, M
Agut, H
Autran, B
Barthalay, Y
Vigne, R
Citation: G. Hassaine et al., Characterization of human immunodeficiency virus type 1 vif gene in long-term asymptomatic individuals, VIROLOGY, 276(1), 2000, pp. 169-180
Authors:
Faure, S
Meyer, L
Costagliola, D
Vaneensberghe, C
Genin, E
Autran, B
Delfraissy, JF
McDermott, DH
Murphy, PM
Debre, P
Theodorou, I
Combadiere, C
Citation: S. Faure et al., Rapid progression to AIDS in HIV+ individuals with a structural variant ofthe chemokine receptor CX(3)CR1, SCIENCE, 287(5461), 2000, pp. 2274-2277
Authors:
Samri, A
Haas, G
Duntze, J
Bouley, JM
Calvez, V
Katlama, C
Autran, B
Citation: A. Samri et al., Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells, J VIROLOGY, 74(19), 2000, pp. 9306-9312
Authors:
Combadiere, B
Blanc, C
Li, TS
Carcelain, G
Delaugerre, C
Calvez, V
Tubiana, R
Debre, P
Katlama, C
Autran, B
Citation: B. Combadiere et al., CD4(+)Ki67(+) lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycle, EUR J IMMUN, 30(12), 2000, pp. 3598-3603
Authors:
Candotti, D
Calvez, V
Autran, B
Costagliola, D
Rouzioux, C
Agut, H
Citation: D. Candotti et al., Decreased peripheral circulation of HIV-infected cells in a subset of long-term nonprogressors, J ACQ IMM D, 21(3), 1999, pp. 253-255
Authors:
Li, TS
Tubiana, R
Fillet, AM
Autran, B
Katlama, C
Citation: Ts. Li et al., Negative result of cytomegalovirus blood culture with restoration of CD4(+) T-cell reactivity to cytomegalovirus after HAART in an HIV-1-infected patient, J ACQ IMM D, 20(5), 1999, pp. 514-515
Authors:
Hadida, F
De Maeyer, E
Cremer, I
Autran, B
Baggiolini, M
Debre, P
Vieillard, V
Citation: F. Hadida et al., Acquired constitutive expression of interferon beta after gene transduction enhances human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity by a RANTES-dependent mechanism, HUM GENE TH, 10(11), 1999, pp. 1803-1810